アポトーシス-シグナル調節キナーゼ1を加速するタンパク質フォスファタゼ5-リクルートキメラ
Qiuyue Zhang1,2, Xuexuan Wu1,2, Hengheng Zhang1,2
1State Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing 210009, China.
Journal of the American Chemical Society
|December 22, 2022
まとめ
研究者らは,PP5をp-ASK1 ((T838) を脱酸化させる新しいキメラであるDDO3711を開発し,胃がんの進行を効果的に減少させました. この標的型アプローチは,異常にリン酸化されたオンコタンパク質の調節に有望である.
科学分野:
- 分子生物学
- 腫瘍学
- 生物化学
背景:
- 異常なタンパク質のリン酸化,特にASK1のようなオンコプロテインの高リン酸化は癌の進行を促します.
- PP5は通常,p-ASK1 (T838) を非酸化するが,腫瘍ではその活性が抑制され,p-ASK1 (T838) のレベルが上昇する.
- タンパク質の脱リン酸化をターゲットにすることで がん治療の戦略が生まれます
研究 の 目的:
- p-ASK1 ((T838) の標的型脱リン化のためのフォスファターゼ募集キメラ (PHORC) の設計と検証.
- ASK1のリン酸化ホメオスタシスを回復することによって,胃がんのための新しい治療戦略を開発する.
主な方法:
- DDO3711の設計は,PP5アクティベーターにリンクされたASK1阻害剤を含むPHORCです.
- DDO3711がp-ASK1 (T838) レベルを低下させる効果を評価するための in vitro および in vivo 実験.
- 胃がん細胞MKN45を用いた抗増殖活性測定
主要な成果:
- DDO3711はp- ASK1 ((T838)) のレベルをin vitroとin vivoで効果的に低下させました.
- DDO3711は,直接結合および近接媒介メカニズムにより,MKN45細胞に対する有意な抗増殖活性を示した (IC50=0. 5μM).
- ASK1阻害剤も,PP5活性化剤も単独または併用してMKN45細胞に効果を示せず,PHORC構造の必要性を強調した.
結論:
- DDO3711で示されたPHORCは,標的型タンパク質の脱リン酸化を加速する効果的なツールです.
- このアプローチは,オンコプロテインの精密なリン酸化調節のための新しい戦略を提供します.
- これらの発見は,PHORCsが異常なリン酸化によって引き起こされるがんに対する新しい治療法を開発する可能性を裏付けています.
関連する概念動画
Amplifying Signals via Enzymatic Cascade
8.6K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
8.6K
PI3K/mTOR/AKT Signaling Pathway
3.8K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.8K
The JAK-STAT Signaling Pathway
9.1K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.1K
Interactions Between Signaling Pathways
6.4K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.4K
Protein Kinases and Phosphatases
13.3K
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
13.3K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K


